Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
MD Anderson Cancer Center
MedTech
Quest Diagnostics taps MD Anderson for cancer risk blood test
Dubbed the multi-cancer stratification test, or MCaST, Quest said it may help identify people who could benefit from more frequent screenings.
Conor Hale
Jun 10, 2025 2:11pm
BD to study HPV self-collection in underserved Texas communities
Nov 21, 2024 10:45am
MD Anderson launches cell therapy institute with $80M
Nov 11, 2024 4:20pm
Generate raises huge $273M series C, a little short of 2021 haul
Sep 14, 2023 6:00am
Alaunos winds down sole cell therapy trial, cuts 60% of staff
Aug 15, 2023 10:53am
Replay, MD Anderson form near-clinical TCR-NK cell therapy firm
Feb 14, 2023 9:30am
